I was diagnosed with triple negative breast cancer when I was 35. I have been without evidence of disease since 2013, after neoadjuvant chemotherapy and a bilateral mastectomy.
Professional Background and Education
I am an academically trained cancer researcher, having earned my PhD from Georgetown University for my research into the interaction between estrogen receptor expression and growth factor signaling in breast cancer after receiving a bachelor’s degree in Biochemistry from the University of Illinois. Now, I draw from my education and my experiences as a breast cancer patient to work with scientists as a research advocate. I am also active in the cancer space professionally as a Molecular Science Liaison for Caris Life Sciences.
Additional Community Affiliations and Memberships
I am an active member of a local support group for breast cancer moms with young kids, and I am a member of #BCSM, a breast cancer group on twitter. I write a breast cancer blog, Run Lipstick Chemo, and was a featured contributor to the Cure Magazine Community. In addition, I am on the Steering Committee for the Coalition for Clinical Trials Awareness and was a Co-Chair of the Planning Committee for the AACR 2019 Annual Meeting.
Why I Became an Advocate
As a scientist, I was impressed by the strong voice that advocates have, and I felt that understanding the science for which they advocate could increase the impact of their message. I also saw the impact that understanding the patient perspective could have on a researcher’s project. I hope to act as a bridge between the medical and research community and the patient community, helping each to better understand the other. Most of all, I want to do all I can to help good science succeed to help those diagnosed with cancer live longer and better lives.
Specialized Advocacy Training and Advocacy Interests
I graduated from the Tumor Biology Training Program at Georgetown University with a PhD in 2004. I have attended both the AACR Scientist <-> Survivor program and the Accelerating Anticancer Agent Development and Validation (AAADV) Fundamentals Workshop which provide specific advocate training. I have served as a reviewer for the DOD Breast Cancer Research Program and the New York Department of Health Peter T. Rowley Breast Cancer Program, and I have served as the patient representative on an ASCO Clinical Guidelines Panel.
Denduluri N, Somerfield MR, Eisen A,Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC. J Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer andAdjuvant Targeted Therapyfor Human Epidermal Growth Factor Receptor 2-PositiveBreast Cancers: An American Society of ClinicalOncology Guideline Adaptation of theCancer Care Ontario Clinical Practice Guideline. J. Clin Oncol. 2016 Apr 18. pii: JCO670182. [Epub ahead of print]
Various contributions to Science 37 blog, Trial Mix.
Holloway, Jamie. When it Comes to Breast Cancer, I Run for Life. Cure 2016.
Holloway, Jamie. Jamie Holloway– Breast Cancer Scientist and Consumer, Jamie Holloway. Department of Defense Congressionally Directed Medical Research Programs: Consumer Stories. 2015.
Holloway, Jamie. Ten Lessons Learned From Having Breast Cancer. Scary Mommy. October 14, 2015.
Holloway, Jamie. The Indignity of Breast Cancer. Cure. 2015.
Holloway, Jamie. An Extraordinary Approach to Metastatic Breast Cancer. Cure. 2015.
Holloway, Jamie. How to Share Your Story. American Association for Cancer Research: Survivor and Patient Advocacy How-To Series. 2015.
Holloway, Jamie. Triumph of Ambivalence. Arlington Magazine 2014 Jan/Feb 4(1): 30-31.
Kulkoyluoglu E, Wrobel K, Chen Zhao Y, Chen KL, Hieronymi K, Holloway J, Landesman Y, Ray T, Ray PS, Lipka AE, Smith RL, Madak Erdogan Z. Targeting nuclear transport pathways to overcome endocrine resistance and recurrence. American Association of Cancer Research, New Orleans, LA, 2016. Abstract # 1812.
Holloway JN, Lucas W, Salamone J, Brundage S, Winarsky S, London M, Greenwood N, Stahl S, Carbine N, Goyes R, Leventhal KG, Isaacs C, Clarke R, Chisolm DC, Ernst E, Price E, and Shajahan-Haq AN. Impact of Patient Advocacy in Breast Cancer Research at Georgetown University Lombardi Comprehensive Cancer Center. American Association of Cancer Research, Philadelphia, PA, 2015. #P27-ADV01.
San Antonio Breast Cancer Symposium, 2015 – Patient Advocates as Partners in Breast Cancer Research at Georgetown-Lombardi Comprehensive Cancer Center (poster)
American Association for Cancer Research, 2016 Annual Meeting – Energizing and Educating to Bridge the Scientist-Patient Advocate Gap (poster)